Results 11 to 20 of about 8,911,089 (208)

Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography [PDF]

Data in Brief, 2019
This article provides additional data on the association of the new adipokine CTRP1 with the incidence of future major adverse cardiovascular events in a prospective cohort of patients undergoing coronary angiography.
Axel Muendlein, Andreas Leiherer, Christoph Saely, Janine Ebner, Kathrin Geiger, Eva Maria Brandtner, Alexander Vonbank, Peter Fraunberger, Heinz Drexel   +8 more
doaj   +4 more sources

Pyoderma Gangrenosum Associated With Major Adverse Cardiovascular Events

JEADV Clinical Practice
Background Pyoderma gangrenosum (PG) is a neutrophilic dermatosis characterized by the rapid onset of painful ulcers. Previous retrospective population‐based studies have identified a relationship between PG and major adverse cardiovascular events (MACE).
Nana Ama Adjei‐Frimpong, Francesco Delacqua, Ben A. Croker, Reid Oldenburg   +3 more
doaj   +4 more sources

The association between thoracic periaortic fat and major adverse cardiovascular events [PDF]

Wiener klinische Wochenschrift, 2015
The study aimed to examine the association between thoracic periaortic fat tissue volume and the long-term incidence of major adverse cardiovascular events.
Keser, Ahmet, Kayrak, Mehmet, Kaya, Zeynettin, Ulucan, Seref, Akyurek, Omer, Katlandur, Huseyin, Efe, Duran   +6 more
core   +3 more sources

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV

JACC: Advances
Background: People with HIV (PWH) are at increased risk for atherosclerotic cardiovascular diseases (ASCVDs) and geriatric syndromes, including frailty.
Kristine M. Erlandson, MD, MS, Ariela R. Orkaby, MD, Triin Umbleja, MSc, Heather J. Ribaudo, PhD, Todd T. Brown, MD, PhD, Markella V. Zanni, MD, Marissa R. Diggs, AB, Sarah M. Chu, MSN, Kathleen V. Fitch, MSN, Carl J. Fichtenbaum, MD, Carlos Malvestutto, MD, MPH, Judith A. Aberg, MD, Gerald S. Bloomfield, MD, MPH, Judith S. Currier, MD, Karen T. Tashima, MD, Marcus Vinícius Guimarães de Lacerda, MD, PhD, Sonya L. Heath, MD, Michael T. Lu, MD, MPH, Alan Landay, PhD, George A. Kuchel, MD, Pamela S. Douglas, MD, Steven K. Grinspoon, MD   +21 more
doaj   +4 more sources

Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study. [PDF]

, 2023
Background While the cardiovascular risks of androgen receptor pathway inhibitors have been studied, they were seldom compared directly. This study compares the risks of major adverse cardiovascular events (MACE) between enzalutamide and abiraterone ...
Jeremy Man Ho Hui, Chi Fai Ng, Chi Ho Leung, Yan Hiu Athena Lee, Christopher Tze Wei Tsang, Paul L. Nguyen, Gary Tse, Kyle Hui, Sean McBride, Pias Tang, Kenrick Ng, Jeffrey Shi Kai Chan, Edward Christopher Dee   +12 more
core   +3 more sources

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events [PDF]

JAMA Network Open, 2022
ImportancePatients with stroke due to nontraumatic (spontaneous) intracerebral hemorrhage (ICH) often harbor vascular risk factors and comorbidities, but it is unclear which major adverse cardiovascular events (MACEs) occur more frequently among patients with a prior ICH than the general population.ObjectiveTo evaluate the risk of a MACE for patients ...
Gaist, David, Hald, Stine Munk, García Rodríguez, Luis Alberto, Clausen, Anne, Möller, Sören, Hallas, Jesper, Al-Shahi Salman, Rustam; id_orcid 0000-0002-2108-9222   +6 more
openaire   +4 more sources

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis [PDF]

Cureus, 2020
Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by which it can affect the cardiovascular system.
Mal, Kheraj, Kumar, Ratan, Mansoor, Farah, Kaur, Navneet, Kumar, Anil, Memon, Sidra, Rizwan, Amber   +6 more
openaire   +2 more sources

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients [PDF]

Reviews on Recent Clinical Trials, 2018
Psoriatic arthritis is a chronic inflammatory arthropathy that affects 14%- 30% of patients with skin and/or nail psoriasis, leading to severe physical limitations and disability. It has been included in the group of spondyloarthropathy with which it shares clinical, radiologic, and serologic features in addition to familial and genetic relationship ...
Peluso, Rosario, Caso, Francesco, Tasso, Marco, Ambrosino, Pasquale, Nicola, Matteo, Di Minno, Dario, Lupoli, Roberta, Criscuolo, Livio, Caso, Paolo, Ursini, Francesco, Del Puente, Antonio, Scarpa, Raffaele, Costa, Luisa   +12 more
openaire   +4 more sources

Predictors for major adverse cardiovascular events.

, 2021
Predictors for major adverse cardiovascular events.
Joo-Hee Zo (721373), Jae-Bin Seo (721370), Myung-A Kim (721372), Woo-Hyun Lim (6157328), Hack-Lyoung Kim (654343), Sang-Hyun Kim (282188), Inki Moon (8293041)   +6 more
core   +1 more source

Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD [PDF]

Clinical Journal of the American Society of Nephrology, 2016
Soluble TNF-like weak inducer of apoptosis (sTWEAK) is a proinflammatory cytokine belonging to the TNF superfamily. sTWEAK concentrations have been associated with the presence of CKD and cardiovascular disease (CVD). We hypothesized that sTWEAK levels may relate to a higher prevalence of atherosclerotic plaques, vascular calcification, and ...
Fernández-Laso, V., Sastre, Cristina, Valdivielso Revilla, José Manuel, Betriu i Bars, M. Àngels, Fernández i Giráldez, Elvira, Egido, Jesús, Martín-Ventura, JL., Blanco-Colio, LM.   +7 more
openaire   +3 more sources